[1]JournaloftheChemicalSociety,PerkinTransactions1:OrganicandBio-OrganicChemistry(1972-1999),1988,p.1521-1526
[1]ChemischeBerichte,1896,vol.29,p.2382
[1]SyntheticCommunications,1995,vol.25,#6,p.907-913
[2]SyntheticCommunications,1995,vol.25,#6,p.907-913
[1]SyntheticCommunications,1995,vol.25,#6,p.907-913
[1]Patent:US2016/176896,2016,A1,.Locationinpatent:Paragraph0119
[2]JournalofOrganicChemistry,2015,vol.80,#20,p.10086-10097
[1]ChemischeBerichte,1896,vol.29,p.2382
[1]BulletindelaSocieteChimiquedeFrance,1943,vol.<5>10,p.347
[1]JournalofMedicinalChemistry,1999,vol.42,p.1587-1603
[2]JournalofOrganicChemistry,2015,vol.80,p.10086-10097
[3]JournaloftheChemicalSociety,1952,p.3524,3526
[1]Chemicalandpharmaceuticalbulletin,1971,vol.19,p.2354-2364
[1]CurrentPatentAssignee:ARBUTUSBIOPHARMACORP-WO2019/191624,2019,A1Locationinpatent:Page/Pagecolumn93;94
[2]Kato;Morie;Hino;Kon;Naruto;Yoshida;Karasawa;Matsumoto[JournalofMedicinalChemistry,1990,vol.33,#5,p.1406-1413]
Title: Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Journal: Bioorganic & medicinal chemistry 20080801